Stewartsville, NJ, United States of America

Joseph H Contiliano

This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph H Contiliano. Retrieved from https://idiyas.com/inventor/joseph-h-contiliano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph H. Contiliano and His Retinal Drug-Delivery Invention.

Introduction

Joseph H. Contiliano is an inventor associated with Stewartsville, New Jersey, and Genentech, Inc. His listed patent concerns a device designed to deliver therapeutic agents to the subretinal region of the eye.

Latest Patents

The provided information lists one patent for Contiliano: “Therapeutic Agent Delivery Device with Convergent Lumen.” The apparatus includes an outer cannula and a movable inner cannula with an open distal end configured to pierce the retina. Its lumen delivers two fluids into the subretinal region. Separate supply conduits feed the fluids, and their distal ends are secured to the inner cannula so they move longitudinally with it. This coordinated movement supports fluid delivery as the cannula advances.

Career Highlights

Contiliano’s listed invention addresses the engineering of a specialized ophthalmic delivery device. The patent describes a configuration intended to combine retinal access with the delivery of two fluids through a shared lumen. The supplied information identifies Genentech, Inc. as his company.

Collaborations

Daniel J. Abbott is identified as Contiliano’s coworker. The available information does not specify their roles or describe a particular joint project.

Conclusion

Joseph H. Contiliano’s listed patent presents a coordinated cannula-and-conduit design for delivering therapeutic fluids to the subretinal region, reflecting a focused contribution to ophthalmic device innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…